Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

DiABZI STING agonist-1

DiABZI STING agonist-1 is a tautomerism of diABZI STING agonist-1 tautomerism. diABZI STING agonist-1 is a selective stimulator of interferon genes (STING) receptor agonist, with EC50s of 130, 186 nM for human and mouse, respectively[1].

Product Specifications

CAS Number

2138299-33-7

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

STING

Type

Reference compound

Related Pathways

Immunology/Inflammation

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/diABZI_STING_agonist-1_Tautomerism.html

Concentration

10mM

Purity

99.86

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

O=C(N)C1=CC(N=C(NC(C2=CC(C)=NN2CC)=O)N3C/C=C/CN4C(NC(C5=CC(C)=NN5CC)=O)=NC6=C4C(OCCCN7CCOCC7)=CC(C(N)=O)=C6)=C3C(OC)=C1

Molecular Formula

C42H51N13O7

Molecular Weight

849.94

Precautions

H302, H315, H319, H335

References & Citations

[1]Ramanjulu JM, et al. Design of amidobenzimidazole STING receptor agonists with systemic activity. Nature. 2018 Nov 7.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture and light)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Citation 01

Adv Sci (Weinh) . 2024 Nov 19:e2407222.|Biomed Pharmacother. 2024 Feb:171:116007.|Cancer Lett. 2024 May 1:589:216836.|Cell Death Differ. 2024 Jan;31 (1) :78-89.|Cell Death Differ. 2025 Jun;32 (6) :1167-1179.|Cell Rep. 2025 Nov 18;44 (12) :116581.|Chin Herb Med. 2024 Apr 30;16 (3) :422-434.|Chin Herb Med. 2025 Jan 7.|Chin Med. 2024 Aug 15;19 (1) :107.|FASEB J. 2025 Apr 15;39 (7) :e70530.|Genes Dis. 2023 Sep 2;11 (6) :101074.|Invest Ophthalmol Vis Sci. 2024 Jun 3;65 (6) :13.|J Exp Med. 2021 Feb 1;218 (2) :e20200887.|University of California San Diego. 2023|ACS Infect Dis. 2022 Mar 11;8 (3) :463-471.|Adv Sci (Weinh) . 2025 Apr;12 (14) :e2417686.|Am J Cancer Res. 2023 May 15;13 (5) :2055-2065.|bioRxiv. 2025 Feb 27:2025.02.21.639458.|bioRxiv. 2025 Jul 18:2025.07.14.664814.|bioRxiv. 2025 Nov 18.|Cancer Lett. 2022 Oct 28:547:215885.|Cancer Lett. 2024 Jun 21:217081.|Cell Death Dis. 2022 Jul 28;13 (7) :653.|Cell Immunol. 2021 Aug:366:104384.|EMBO J. 2025 Jan;44 (1) :141-165.|Exp Hematol Oncol. 2024 Aug 5;13 (1) :77.|Front Immunol. 2020 Jul 8:11:1430.|Front Pharmacol. 2023 Apr 4:14:1160445.|J Bone Miner Res. 2024 Jun 14:zjae093.|J Ethnopharmacol. 2024 Aug 17:118661.|J Invest Dermatol. 2022 Apr;142 (4) :1158-1170.e8.|Mol Cell. 2023 May 4;83 (9) :1502-1518.e10.|Nat Nanotechnol. 2021 Nov;16 (11) :1260-1270.|OncoImmunology. 2022 Feb 1;11 (1) :2030021.|PLoS One. 2021 Oct 27;16 (10) :e0258989.|Proc Natl Acad Sci U S A. 2023 Jan 31;120 (5) :e2213777120.|Protein Cell. 2022 Apr;13 (4) :281-301.|Sci China Life Sci. 2024 Dec;67 (12) :2664-2677.|Sci Rep. 2022 Oct 24;12 (1) :17827.|Thorac Cancer. 2022 May; 13 (9) : 1361–1368.|World J Tradit Chin Med. 2025 April 17.|World J Tradit Chin Med. 2025 Oct 28.

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

FUBP3 Rabbit Polyclonal Antibody
TA365991 100 µL

FUBP3 Rabbit Polyclonal Antibody

Sign In for Pricing
View Details
2',3',4,4',5-Pentachlorobiphenyl
TRC-P238195-10MG 10 mg

2',3',4,4',5-Pentachlorobiphenyl

Sign In for Pricing
View Details
Triethylamine-d15
TRC-T797473-500MG 500 mg

Triethylamine-d15

Sign In for Pricing
View Details
TINAG (NM_014464) Human Over-expression Lysate
LY402341 100 µg

TINAG (NM_014464) Human Over-expression Lysate

Sign In for Pricing
View Details
MAN1C1 Human Gene Knockout Kit (CRISPR)
KN422009 1 Kit

MAN1C1 Human Gene Knockout Kit (CRISPR)

Sign In for Pricing
View Details
CD54 / ICAM-1 (15.2), CF647 conjugate, 0.1mg/mL
BNC472853-100 1x 100 µL

CD54 / ICAM-1 (15.2), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details